Pharmacosmos
Focus: Pharmacosmos is a Denmark-based biotech specializing in iron deficiency medicines and oncology support therapies, with a highly focused commercial portfolio generating 100% revenue from COSELA (trilaciclib).
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Pharmacosmos
AI assessmentNot HiringNo open roles listed right now. Follow Pharmacosmos to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
25 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$80K Part DStable
Peak14.5yr
Primary revenue driver (100% of company revenue) with 16-year patent runway; NDA-approved with oncology focus in lung and breast cancer.
Help build intelligence for Pharmacosmos
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.